GenSight Biologics【SIGHT】銘柄情報 | ADVFN

US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

ホーム
投資
株式
ヨーロッパ
EU
GenSight Biologics S.A. (SIGHT) 銘柄情報

GenSight Biologics S.A. (SIGHT)

0.31

-0.005

(-1.59%)

終了 12月5日 1:30AM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.31

買値

0.308

売値

0.315

出来高

157,658

0.31 日の範囲 0.315

0.28 52 週間の範囲 0.598

時価総額

前日終値

0.315

始値

0.315

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

368,694

発行済株式数

78,370,724

配当利回り

-

PER

-0.93

1 株当たり利益 (EPS)

-0.33

歳入

2.96M

純利益

-26.22M

セクター

Biological Pds,ex Diagnstics

業界

Biological Pds,ex Diagnstics

ウェブサイト

www.gensight-biologics.com

本社

Paris, Paris, Fra

設立

-

GenSight Biologics S.A. is listed in the Biological Pds,ex Diagnstics sector of the ユーロネクスト with ticker SIGHT. The last closing price for GenSight Biologics was 0.32 €. Over the last year, GenSight Biologics shares have traded in a share price range of 0.28 € to 0.598 €.

GenSight Biologics currently has 78,370,724 shares in issue. The market capitalisation of GenSight Biologics is 24.69 € million. GenSight Biologics has a price to earnings ratio (PE ratio) of -0.93.

GenSight Biologics announces a financing for an amount of c. €2.8 million from existing investors

Regulatory News: This press release is not being made in and copies of It may not be distributed or sent, directly or indirectly, into the United States, Canada, South Africa, Japan or...

GENSIGHT BIOLOGICS : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Article 223-16 du règlement Général de l’AMF Regulatory News : GENSIGHT BIOLOGICS (Paris:SIGHT) : (Code ISIN : FR0013183985) Date Nombre d’actions composant le capital Nombre de droits de vote...

GenSight Biologics : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Article 223-16 du règlement Général de l’AMF Regulatory News: GenSight Biologics (Paris:SIGHT) (Code ISIN : FR0013183985): Date Nombre d’actions composant le capital Nombre de droits de vote...

GENSIGHT BIOLOGICS : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Article 223-16 du règlement Général de l’AMF Regulatory News: GENSIGHT BIOLOGICS (Paris:SIGHT): Date Nombre d’actions composant le capital Nombre de droits de vote brut1 Nombre de droits de...

GENSIGHT BIOLOGICS: Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Article 223-16 du règlement Général de l’AMF Regulatory News: GENSIGHT BIOLOGICS (Paris:SIGHT): (Code ISIN : FR0013183985) Date Nombre d’actions composant le capital Nombre de droits de vote...

GENSIGHT BIOLOGICS : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Article 223-16 du règlement Général de l’AMF Regulatory News: GENSIGHT BIOLOGICS (Paris:SIGHT) (Code ISIN : FR0013183985) Date Nombre d’actions composant le capital Nombre de droits de vote...

GENSIGHT BIOLOGICS : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Article 223-16 du règlement Général de l’AMF Regulatory News: GENSIGHT BIOLOGICS (Paris:SIGHT) (Code ISIN : FR0013183985) Date Nombre d’actions composant le capital Nombre de droits de vote...

GENSIGHT BIOLOGICS : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Article 223-16 du règlement Général de l’AMF Regulatory News: GENSIGHT BIOLOGICS (Paris:SIGHT) (Code ISIN : FR0013183985) Date Nombre d’actions composant le capital Nombre de droits de vote...

GENSIGHT BIOLOGICS : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Article 223-16 du règlement Général de l’AMF Regulatory News: GENSIGHT BIOLOGICS (Paris:SIGHT) (Code ISIN : FR0013183985) Date Nombre d’actions composant le capital Nombre de droits de vote...

GENSIGHT BIOLOGICS : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Article 223-16 du règlement Général de l’AMF Regulatory News: GENSIGHT BIOLOGICS (Paris:SIGHT) (Code ISIN : FR0013183985) Date Nombre d’actions composant le capital Nombre de droits de vote...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.004	1.30718954248	0.306	0.3735	0.301	677820	0.34548104	DE
4	-0.0125	-3.87596899225	0.3225	0.3735	0.29	325209	0.33255443	DE
12	-0.0595	-16.1028416779	0.3695	0.448	0.28	368694	0.34908765	DE
26	-0.0595	-16.1028416779	0.3695	0.496	0.28	309533	0.36160018	DE
52	-0.189	-37.875751503	0.499	0.598	0.28	214330	0.38161132	DE
156	-4.91	-94.061302682	5.22	6.135	0.28	207167	1.43400335	DE
260	-0.84	-73.0434782609	1.15	9.69	0.28	298199	3.21854307	DE

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
ALCOXNicox SA	0.2895 € (32.49%)	1.34M
ALGTRGroupe Tera SA	2.40 € (28.34%)	410
ALSAFSAFE	0.086 € (23.92%)	80.01k
ALAGOEPango SA	0.1062 € (16.45%)	2.54M
MLCMIScemi	3.96 € (14.45%)	4
ALCYBCybergun	0.0001 € (-50.00%)	2.68M
ALTMENoxxon Pharma NV	0.0896 € (-42.34%)	4.69M
GNROGeNeuro SA	0.0428 € (-34.56%)	1.05k
ALEUPEuroplasma	0.047 € (-32.86%)	2.61M
ATOAtos SE	0.339 € (-31.52%)	14.65M
ALNEVNeovacs	0.0003 € (0.00%)	52.59M
BCPBanco Comercial Portugues SA	0.4469 € (0.27%)	34.35M
ATOAtos SE	0.339 € (-31.52%)	14.65M
ORAOrange.	9.414 € (-3.01%)	14.62M
ALHPIHopium SA	0.0089 € (3.49%)	11.09M

uber darthium

uber darthium 5分前

I found this from Bowie

An appointed receiver is generally required to report any suspected fraud they discover while managing assets during a receivership, as they have a fiduciary duty to the court and must act in good faith to protect the interests of all parties involved; if the

goldslacker2023

goldslacker2023 5分前

Interesting.

Trump Taps Fmr Commissioner Paul Atkins to Run SEC:
U.S. Republican President-elect Donald Trump Wednesday said he would nominate Paul Atkins to run the Securities and Exchange Commission, putting a prominent conservative Washington insider atop Wall Street's majo

DTGoody

DTGoody 6分前

As long as the company comes through it won't matter what is posted on the board. I have seen that time and time again.

There was another stock that was being bashed to death for the last couple of years and all of sudden the company came through and that stock is now up 800% and pro

lakers17

lakers17 7分前

Another BTC all time high, $103,900. Should trickle down to all the others. It's been a delayed effect. Great times in crypto. At least this time I already owned instead of buying at the highs in early 2021. I am way up now with more to come. Finally just taking the ride, locked and loaded and

boi568

I think the interviewer had a rather long list of questions to ask in a relatively short time. This inevitably led to some truncated answers. However, I had no trouble following the conversation. I'm sure that wasn't true for a relative newcomer to the company.

1vman

*****🚽UBQU🚽 Total liabilities and shareholders deficit has grown from 196,696 to 3,828,183 million in just 1 year

https://www.otcmarkets.com/otcapi/company/financial-report/414119/content

ENOUGH SAID HUZZAH🤪 !!!

Konaploinks

Konaploinks 7分前

What came first? The Nene Goose? Or the egg?

1vman

***** 🚽HCWC🚽 Sales down , volume shriveling up , not l👀king good here - Wh👀ps

HUZZAH🤔 !!! ENOUGH SAID😃 !!!

Konaploinks

Konaploinks 9分前

Nice close A H. Showing strong support imo. I say that and for sure it will tank 4.00 in the morning😡. WTF? No one ever gets it right. We need our own quantum computers in our phones to run all possible outcomes. Then maybe everyone could make money? But if everyone made money and no one lo

StayHumble

StayHumble 10分前

🎃Yes✅Win-Win $UBQU erases $2Million💹of debt in 12months✅

https://www.otcmarkets.com/stock/UBQU/news/EQS-News-Ubiquitech-Software-Corp-OTCUBQU-Successfully-Eliminates-Additional-Convertible-Debt-Bringing-Recent-Total-Elim?id=444198

Stinger2014

Stinger2014 11分前

Great buys! Good DD. BTC is lighting a fuse, sturing the pot.

elks

O BOY LFG !!!!!!!!!!!

Running Q

Running Q 14分前

Facts. As a moderator of this board can you restrict his negativity and baseless posts?

dinogreeves

dinogreeves 14分前

Memphis here we come.

https://www.youtube.com/watch?v=VejztsaQEeQ

Stinger2014

Stinger2014 14分前

And….. Kaboomtacks = miner sales AND upgrades!!

1vman

*****🚽HCMC🚽53.1 -Million XPERT Sells as the bail out continues merrily along

https://ih.advfn.com/stock-market/USOTC/healthier-choices-manage-pk-HCMC/trades

ENOUGH SAID HUZZAH🤪!!!

StayHumble

StayHumble 14分前

Full YEAR SALES $55M+Up90%💹💹GrossProfit $20M+Up 99%💹💹
https://www.healthiercmc.com/news/240327-hcmc-q4-2023-results

INEEDMONEY

INEEDMONEY 15分前

Bitcoin climb is good . But has nothing to do with our pps. U fortunately dosent follow it. But I believe this merger will send us high ! I loaded from .0001 right before the merger and then loaded more at .0005 yesterday. Holding for penny land

Pickme2

Pickme2 16分前

Little man your no threat to anybody here.. your little manipulative buys and sells mean nothing... you've been exposed for who you are... lying cheat con artist...

Whalatane

Whalatane 16分前

Hmmm. I remember you making the same claim at $20 " why sell now it'll be bt out for $40 "........." .smart play now "....all the way down to 50c .
Well Ok ...best of luck for a " good " repeat
Kiwi

Konaploinks

Konaploinks 16分前

Just when u thought u were done with your Homework 🤬 Honeywell. Hmmm
Barium and ytterbium are both elements used in quantum computing, particularly in systems that rely on trapped-ion quantum technology. Each has unique properties that make it suitable for specific applications in qua

ToucanYoucan

ToucanYoucan 16分前

This dog actually had some volume today.....at $.0001. I don't know what to think of that.
Tax write-offs usually have about 20 zeroes.....lol.
This may be an actual trade where somebody got $19.
I'll be darned.

moondogaz

moondogaz 17分前

Imo.. the mms will try to take longs out,before eoy.

Stinger2014

Stinger2014 18分前

$CGAC= miners and a company that sells miner equipment. Pinch me! BTC next leg 150K!!

GenSight Biologics

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約